Cao, S., Durrani, F. A., Toth, K., Rustum, Y. M., & Seshadri, M. (2011). Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts.
Stile di citazione ChicagoCao, Shousong, Farukh A. Durrani, Karoly Toth, Youcef. M. Rustum, e Mukund Seshadri. Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts. 2011.
Citazione MLACao, Shousong, et al. Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts. 2011.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.